Quidel Receives FDA Clearance for Solana(R) Influenza A+B Assay
Quidel has received marketing clearance from the FDA for its Solana Influenza A+B assay.
It is designed to detect nucleic acids isolated from nasal and nasopharyngeal swabs from patients with signs and symptoms of respiratory infection.
The diagnostic device is intended for use only with the Solana instrument.
The device produces results in under an hour. — Cynthia Jessup